The risk of a blood clot caused by hormonal contraceptives falls rapidly once it is no longer used, new research indicates, with most of this fall happening within two to four weeks.
It has long been known that combined hormonal contraceptives – i...
3 months ago
Researchers have reported new insights into the mechanisms of how B-cell cancers become resistant to CD20-targeting immunotherapies, offering hopes of improving survival.
Therapies such as rituximab target the CD20 protein found on healthy and can...
3 months ago
